Mallinckrodt public limited company (MNK)
US Market

Mallinckrodt public limited company (MNK) Stock Price & Analysis


MNK Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.10 - $31.00
Previous Close$1.31
Average Volume (3M)1.48M
Market Cap
Enterprise Value$2.61B
Total Cash (Recent Filing)$480.00M
Total Debt (Recent Filing)$3.09B
Price to Earnings (P/E)>-0.1
Aug 08, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-78.90
Shares Outstanding13,170,932
10 Day Avg. Volume298,906
30 Day Avg. Volume1,481,156
Standard Deviation0.24
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)0.04
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.41
Enterprise Value/Gross Profit53.54
Enterprise Value/Ebitda-3.43
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Mallinckrodt public limited company’s price range in the past 12 months?
Mallinckrodt public limited company lowest stock price was $0.10 and its highest was $31.00 in the past 12 months.
    What is Mallinckrodt public limited company’s market cap?
    Currently, no data Available
    When is Mallinckrodt public limited company’s upcoming earnings report date?
    Mallinckrodt public limited company’s upcoming earnings report date is Aug 08, 2023 which is in 59 days.
      How were Mallinckrodt public limited company’s earnings last quarter?
      Mallinckrodt public limited company released its earnings results on May 09, 2023. The company reported -$18.886 earnings per share for the quarter, missing the consensus estimate of N/A by -$18.886.
        Is Mallinckrodt public limited company overvalued?
        According to Wall Street analysts Mallinckrodt public limited company’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Mallinckrodt public limited company pay dividends?
          Mallinckrodt public limited company does not currently pay dividends.
          What is Mallinckrodt public limited company’s EPS estimate?
          Mallinckrodt public limited company’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Mallinckrodt public limited company have?
          Mallinckrodt public limited company has 13,170,932 shares outstanding.
            What happened to Mallinckrodt public limited company’s price movement after its last earnings report?
            Mallinckrodt public limited company reported an EPS of -$18.886 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -26.19%.
              Which hedge fund is a major shareholder of Mallinckrodt public limited company?
              Among the largest hedge funds holding Mallinckrodt public limited company’s share is Cyrus Capital Partners, L.P.. It holds Mallinckrodt public limited company’s shares valued at N/A.


                Mallinckrodt public limited company Stock Smart Score

                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Mallinckrodt public limited company

                Mallinckrodt PLC develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies. Its areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. The company operates its business in two reportable segments namely Specialty Brands which includes innovative specialty pharmaceutical brands; and Specialty Generics which includes niche specialty generic drugs and active pharmaceutical ingredients. It generates maximum revenue from the Specialty Brands segment. Geographically, it derives a majority of revenue from the United States.


                Top 5 ETFs holding MNK

                Market Value
                Smart Score
                Schwab U.S. Broad Market ETF
                Up to five ETFs with an Outperform Smart Score that hold MNK. The ETFs are listed according to market value of MNK within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Jazz Pharmaceuticals
                Perrigo Company
                GH Research
                Avadel Pharmaceuticals

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis